Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Oculis SA Oculis Announces Partial Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares June 13, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares May 31, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis Announces Launch of Proposed Public Offering of Ordinary Shares May 30, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis to Participate and Present at Upcoming EuDES Meeting May 24, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops May 22, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis Co-founders Selected as Finalists in European Inventor Award 2023 May 11, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis Opens New Offices in the US and Expands its US Team by Appointing Dr. Fang Li as Senior Vice President, Regulatory Affairs April 26, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis to Participate at Upcoming Investor Conferences April 05, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones April 04, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing March 22, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial March 16, 2023 From Oculis SA Via GlobeNewswire Tickers OCS Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.